Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
OGN — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

7.27

Margin Of Safety %

27

Put/Call OI Ratio

0.96

EPS Next Q Diff

0.34

EPS Last/This Y

2.9

EPS This/Next Y

0.02

Price

13.55

Target Price

12.33

Analyst Recom

3.2

Performance Q

137.72

Upside

-9.8%

Beta

1.53

Ticker: OGN




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-06-02OGN13.40.750.79154202
2026-06-03OGN13.40.752.55154265
2026-06-04OGN13.40.751.36154831
2026-06-05OGN13.380.764.04155175
2026-06-08OGN13.390.762.12155570
2026-06-09OGN13.390.770.61155919
2026-06-10OGN13.390.770.57156009
2026-06-11OGN13.470.770.65156023
2026-06-12OGN13.440.770.28156057
2026-06-15OGN13.450.770.06156130
2026-06-16OGN13.420.770.13156354
2026-06-17OGN13.420.770.08156519
2026-06-18OGN13.430.770.67156613
2026-06-22OGN13.40.950.78127592
2026-06-23OGN13.460.961.66127686
2026-06-24OGN13.480.962.60127701
2026-06-25OGN13.480.961.62127708
2026-06-26OGN13.50.961.33127791
2026-06-29OGN13.550.960.95127822
2026-06-30OGN13.550.960.09127919
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-06-01OGN13.38-7.9- 3.44
2026-06-02OGN13.37-7.9- 3.44
2026-06-03OGN13.40-7.9- 3.44
2026-06-04OGN13.40-7.9- 3.44
2026-06-05OGN13.38-7.9- 3.44
2026-06-08OGN13.39-7.9- 3.44
2026-06-09OGN13.39-7.9- 3.44
2026-06-10OGN13.38-7.9- 3.44
2026-06-11OGN13.47-7.9- 3.44
2026-06-12OGN13.45-7.9- 3.44
2026-06-15OGN13.46-7.9- 3.44
2026-06-16OGN13.42-7.9- 3.44
2026-06-17OGN13.43-7.9- 3.44
2026-06-18OGN13.42-7.9- 3.44
2026-06-22OGN13.39-7.9- 3.44
2026-06-23OGN13.45-7.9- 3.44
2026-06-24OGN13.48-7.9- 3.44
2026-06-25OGN13.48-7.9- 3.44
2026-06-26OGN13.507.0- 3.62
2026-06-29OGN13.557.0- 3.62
2026-06-30OGN13.557.0- 3.62
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-06-02OGN2.140.227.67
2026-06-03OGN2.140.227.67
2026-06-04OGN2.140.227.67
2026-06-05OGN2.140.227.67
2026-06-08OGN2.14-0.067.67
2026-06-09OGN2.14-0.067.67
2026-06-10OGN2.14-0.066.92
2026-06-11OGN2.14-0.066.92
2026-06-12OGN2.14-0.066.92
2026-06-15OGN2.14-0.146.92
2026-06-16OGN2.14-0.146.92
2026-06-17OGN2.14-0.146.92
2026-06-18OGN2.14-0.146.92
2026-06-22OGN2.14-0.496.92
2026-06-23OGN2.01-0.496.92
2026-06-24OGN2.01-0.496.92
2026-06-25OGN2.01-0.496.92
2026-06-26OGN2.01-0.497.28
2026-06-29OGN2.01-0.497.28
2026-06-30OGN2.01-0.497.27
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.71

Avg. EPS Est. Current Quarter

1.07

Avg. EPS Est. Next Quarter

1.05

Insider Transactions

2.01

Institutional Transactions

-0.49

Beta

1.53

Average Sales Estimate Current Quarter

1556

Average Sales Estimate Next Quarter

1568

Fair Value

17.15

Quality Score

64

Growth Score

54

Sentiment Score

84

Actual DrawDown %

65.7

Max Drawdown 5-Year %

-82.7

Target Price

12.33

P/E

14.44

Forward P/E

3.76

PEG

3.19

P/S

0.58

P/B

3.94

P/Free Cash Flow

5.21

EPS

0.94

Average EPS Est. Cur. Y​

3.62

EPS Next Y. (Est.)

3.64

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.99

Relative Volume

0.21

Return on Equity vs Sector %

-0.5

Return on Equity vs Industry %

-11.1

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.18

EBIT Estimation

OGN Healthcare
$13.55
📉
Swing / Pullback
Buy the dip on strong trends
36 /100
WEAK
Trend
0/20
Pullback
8/25
Volume
11/15
Valuation
10/20
TP/AR
2/10
Options
5/10
RSI
74.7
Range 1M
78.1%
Sup Dist
0.3%
🚀
Momentum Growth
Ride accelerating trends
N/A
27 /100
WEAK
Momentum
7/25
Growth
6/30
Estimates
5/20
Inst/Vol
4/15
Options
5/10
EPS Yr
-7.4%
EPS NY
6.3%
52W%
99.4%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +130.8% upside
Quality
14/30
Valuation
26/30
Growth
7/25
Stability
4/10
LT Trend
1/5
Upside
+130.8%
Quality
64
MoS
27%
OGN — P/E HistoricalDrug Manufacturers - General
Organon & Co.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 10000
Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote development of ovarian follicles; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding and hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; oncology products, including Ontruzant and Aybintio; Bildyos and Bilprevda, a recombinant anti-RANKL human monoclonal antibodies; and Poherdy, a neu receptor antagonist. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products to control and prevent asthma symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company serves drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey.
OGN

Latest News

Caricamento notizie per OGN
stock quote shares OGN – Organon & Co. Stock Price stock today
news today OGN – Organon & Co. stock forecast ,stock prediction 2023 2024 2025
marketwatch OGN – Organon & Co. yahoo finance google finance
stock history OGN – Organon & Co. invest stock market
stock prices OGN premarket after hours
ticker OGN fair value insiders trading